Research Projects & Grants

For Profit Organization

• Apollomics Inc. APL-101-01 (SPARTA): Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors, Role: Investigator, Apollomics Inc., (09/2025 - 09/2026) Status: Approved

Internal

• Investigator initiated CIPNGRASP: A pilot study of intraneural facilitation for managing chemotherapy-induced peripheral neuropathy, Role: Investigator, LLU Dept. of Medicine, (03/2026 - 03/2027) Status: Approved
• Investigator Initiated Retrospective Chart Review: Identify risk factors for cardiovascular complications in patients undergoing cancer treatment, Role: Investigator, LLU Dept. of Medicine, (06/2021) Status: Approved
• Investigator Initiated: Creation of registry for patients receiving neoadjuvant systemic therapy for Breast Cancer, Role: Investigator, LLU Dept. of Medicine, (01/2021) Status: Approved
• Brain and spine tumors in pediatric and adult patients and their survival outcomes, Role: Investigator, LLU Dept. of Pediatrics, (11/2024) Status: Approved
• Establishing Cerebrospinal Fluid Liquid Biopsy as A Reliable Specimen for Diagnosing, Characterizing and Following Up on Central Nervous System Tumors Using Cell-free DNA sequencing, Role: Investigator, LLU Dept. of Pathology & Human Anatomy, (11/2024) Status: Approved
• LLU Cancer Center biospecimen laboratory - specimens collection protocol, Role: Investigator, LLU Cancer Center, (09/2025 - 09/2026) Status: Approved